Innate Pharma S.A. (IPHYF)
OTCMKTS
· Delayed Price · Currency is USD
1.450
-0.310 (-17.61%)
At close: Apr 11, 2025
Innate Pharma Employees
Innate Pharma had 181 employees as of December 31, 2024. The number of employees increased by 2 or 1.12% compared to the previous year.
Employees
181
Change (1Y)
2
Growth (1Y)
1.12%
Revenue / Employee
$115,090
Profits / Employee
-$282,970
Market Cap
167.49M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
SS Innovations International | 378 |
Endo Inc. | 3,116 |
Elite Pharmaceuticals | 64 |
Northwest Biotherapeutics | 25 |
Glass House Brands | 374 |
CytoDyn | 9 |
American Oncology Network | 1,914 |
Longduoduo Company | 49 |
Innate Pharma News
- 21 days ago - Innate Pharma to Participate in the 2025 Stifel Virtual Targeted Oncology Forum - Business Wire
- 4 weeks ago - Innate Pharma S.A. (IPHA) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Innate Pharma S.A. 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 4 weeks ago - Innate Pharma reports FY results - Seeking Alpha
- 4 weeks ago - Innate Pharma Reports Full Year 2024 Financial Results and Business Update - Business Wire
- 4 weeks ago - Innate Pharma Highlights Antibody Drug Conjugate IPH4502 Abstract Selected for the AACR 2025 Annual Meeting - Business Wire
- 4 weeks ago - Innate Pharma announces its participation in the Life Sciences Van Lanschot Kempen Conference - Business Wire
- 4 weeks ago - Innate Pharma: Moving Into The Padcev Space - Seeking Alpha